SEEL vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW
Should you be buying Seelos Therapeutics stock or one of its competitors? The main competitors of Seelos Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.
Seelos Therapeutics vs.
180 Life Sciences (NASDAQ:ATNFW) and Seelos Therapeutics (NASDAQ:SEEL) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Seelos Therapeutics has a net margin of 203.13% compared to 180 Life Sciences' net margin of 0.00%.
23.4% of Seelos Therapeutics shares are owned by institutional investors. 1.1% of Seelos Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, 180 Life Sciences had 1 more articles in the media than Seelos Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Seelos Therapeutics. 180 Life Sciences' average media sentiment score of 1.89 beat Seelos Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.
180 Life Sciences has higher earnings, but lower revenue than Seelos Therapeutics.
Seelos Therapeutics received 71 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
Summary
Seelos Therapeutics beats 180 Life Sciences on 5 of the 8 factors compared between the two stocks.
Get Seelos Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SEEL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Seelos Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:SEEL) was last updated on 4/26/2025 by MarketBeat.com Staff
Buy SEEL Stock Free SEEL Stock Alerts